B&M: So David, let’s start by you just telling me a little bit about your VC firm, what is your history and your key focus? DG: Index was founded in 1996. In the…
Eddie Blair, CEO, GeneFirst, a biotech in the business of modernising molecular diagnostics, spoke to me about his funding strategy and how he is addressing the challenges. He is using…
It is proving harder and harder for early stage biotech’s in the UK to get funding from VCs. Many are hoping high net worth individuals can fill the void. I…
